PEG-Filgrastim activity on granulocyte functions

Leukemia Research

Volumn 31, Issue 10, 2007, Pages 1453-1455

  Fazzi, Rita ^a   Orciuolo, Enrico ^a   Trombi, Luisa ^a   Mattii, Letizia ^a   Battola, Barbara ^a   Riccioni, Rossella ^a   Carulli, Giovanni ^a   Galimberti, Sara ^a   Petrini, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; F ACTIN; LIPOPOLYSACCHARIDE; MACROGOL; PEGYLATED RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; UNCLASSIFIED DRUG; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CELL STRUCTURE; CYTOSKELETON; DRUG CONJUGATION; DRUG EFFECT; DRUG MEGADOSE; GRANULOCYTE; HUMAN; LETTER; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; RISK REDUCTION;

ACTINS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOTTING, WESTERN; FILGRASTIM; GRANULOCYTES; HUMANS; LYMPHOMA, FOLLICULAR; RHOA GTP-BINDING PROTEIN;

EID: 34547747858     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.11.016     Document Type: Letter

References (14)

1. Azzarà A., Carulli G., Rizzuti-Gullaci A., Capochiani E., and Petrini M. Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis. Am J Hematol 66 (2001) 306-307
2. Howard T.H., and Meyer W.H. Chemotactic peptide modulation of actin assembly and locomotion in neutrophils. J Cell Biol 98 (1984) 1265-1271
3. Leavey P.J., Sellins K.S., Thurman G., et al. In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro. Blood 92 (1998) 4366-4374
4. Mattii L., Azzara A., Fazzi R., et al. Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA. Leuk Res 29 (2005) 1285-1292
5. Kalkman P.M., Fokkens W.J., de Wit H.J., et al. A hampered chemoattractant-induced cytoskeletal rearrangement in granulocytes of patients with unexplained severe chronic and relapsing infections of the upper and lower airways. In vitro restoration by G-CSF exposure. Clin Exp Immunol 127 (2002) 115-122
6. Carulli G., Mattii L., Azzarà A., et al. Actin polymerization from donors of peripheral blood stem cells: divergent effects of glycosilated and nonglycosilated recombinant human granulocyte colony stimulating factor. Am J Hematol 81 (2006) 318-323
7. Mattii L., Fazzi R., Moscato S., et al. Carboxy-terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA. J Cell Biochem 93 (2004) 1231-1241
8. Niggli V. Rho-kinase in human neutrophils: a role in signalling for myosin light chain phosphorylation and cell migration. FEBS Lett 445 (1999) 69-72
9. Alblas J., Ulfman L., Hordijk P., and Koenderman L. Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes. Mol Biol Cell 12 (2001) 2137-2145
10. Anderson S.I., Hotchin N.A., and Nash G.B. Role of the cytoskeleton in rapid activation of CD11b/CD18 function and its subsequent downregulation in neutrophils. J Cell Sci 113 Pt 15 (2000) 2737-2745
11. Hall A. Rho GTPases and the actin cytoskeleton. Science 279 (1998) 509-514
12. Curran M.P., and Goa K.L. Pegfigrastim. In this form, renal elimination is decreased with a consequent increased half life of the drug. Drugs 62 (2002) 1207-1213
13. Zamboni W.C. Pharmacokinetics of pegfilgrastim. Pharmacotherapy 23 (2003) 9S-14S
14. Banyard J., Anand-Apte B., Symons M., and Zetter B.R. Motility and invasion are differentially modulated by Rho family GTPases. Oncogene 19 (2000) 580-591